Showing results (1-10 of 745) with videos related to
Sort By:
Pageof 75
Cleveland Clinic Journal of Medicine|August 27, 2005
Demystifying triglycerides: a practical approach for the clinicianRichard L Dunbar, Daniel J RaderCurrent Treatment Options in Cardiovascular Medicine|May 26, 2005
Current Drug Options for Raising HDL CholesterolRichard L Dunbar, Daniel J RaderScience Translational Medicine|July 24, 2010
Could exercise metabolomics pave the way for gymnomimetics?Megan F Burke, Richard L Dunbar, Daniel J RaderThe American Journal of Cardiology|November 30, 2014
Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 levels in patients with dyslipidemiaAmit V Khera, Arman Qamar, Muredach P Reilly, et al.Journal of the American Heart Association|October 30, 2018
Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to NiacinSony Tuteja, Liming Qu, Marijana Vujkovic, et al.Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.Pharmacogenetics and Genomics|June 20, 2017
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapySony Tuteja, Lu Wang, Richard L Dunbar, et al.The American Journal of Medicine|February 27, 2007
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitusDaniel J RaderThe American Journal of Cardiology|December 6, 2007
Liver X receptor and farnesoid X receptor as therapeutic targetsDaniel J RaderPageof 75